Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).
Journal: Cancer
Published: September 05, 2025
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 02, 2022
Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis.
Journal: Laryngoscope investigative otolaryngology
Published: October 06, 2021
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 08, 2020
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 30, 2018
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 13, 2018
Effectiveness Outcomes in Patients With Recurrent or Refractory Head and Neck Cancers: Retrospective Analysis of Data From a Community Oncology Database.
Journal: Clinical therapeutics
Published: April 18, 2018
Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008-2015.
Journal: Clinical genitourinary cancer
Published: February 23, 2018
Patient Characteristics and Costs in Recurrent or Refractory Head and Neck Cancer: Retrospective Analysis of a Community Oncology Database.
Journal: Clinical therapeutics
Published: October 02, 2017
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 10, 2017
Expanding the search for significant EGFR mutations in NSCLC outside of the tyrosine kinase domain with next-generation sequencing.
Journal: Medical oncology (Northwood, London, England)
Published: May 10, 2017
Last Updated: 09/26/2026